| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$19 |
Trading Halt
|
15 Dec 2025 9:15AM |
$0.019 |
$0.019 |
fallen by
0%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurotech International Limited requested a trading halt.
- The halt is pending an announcement about capital raising.
- The halt will last until December 17, 2025, or the announcement release.
- The trading halt request was authorized by Dr. Anthony Filippis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kogan.com Ltd (KGN) ORDINARY FULLY PAID |
Consumer Discretionary |
$323 |
Update - Notification of buy-back - KGN
|
15 Dec 2025 9:15AM |
$3.240 |
$3.230 |
fallen by
0.31%
|
|
| Entertainment Rewards Ltd (EAT) ORDINARY FULLY PAID |
Communication Services |
$27 |
Change in substantial holding
|
15 Dec 2025 9:14AM |
$0.022 |
$0.021 |
fallen by
4.55%
|
|
| Brookside Energy Limited (BRK) ORDINARY FULLY PAID |
Energy |
$44 |
Update - Notification of buy-back - BRK
|
15 Dec 2025 9:14AM |
$0.475 |
$0.455 |
fallen by
4.21%
|
|
| IperionX Limited (IPX) ORDINARY FULLY PAID |
Materials |
$1,672 |
IperionX & Carver Pump to Accelerate Production for US Navy
|
15 Dec 2025 9:14AM |
$5.350 |
$4.980 |
fallen by
6.92%
|
|
IPX - Price-sensitive ASX Announcement
Full Release
Key Points
- IperionX Limited is collaborating with Carver Pump to accelerate critical component production for U.S. Navy ships.
- The project focuses on reducing lead times for titanium components, which are crucial for naval shipbuilding.
- IperionX will use its advanced titanium metal powder to manufacture components in less than one week.
- The partnership aims to overcome supply chain constraints affecting traditionally cast titanium parts.
- Successful prototyping and testing could lead to larger-scale production agreements.
- The total value of the purchase order from Carver Pump is approximately US$100,000.
- Manufacturing of prototype impellers is expected to be complete by May 2026.
- IperionX’s technologies contribute to resolving supply chain challenges within the U.S. defense industrial base.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Biotron Limited (BIT) ORDINARY FULLY PAID |
Health Care |
$5 |
Security Class Suspension from Quotation - BITO
|
15 Dec 2025 9:14AM |
$0.003 |
$0.003 |
fallen by
16.67%
|
|
BIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension from quotation of Biotron Limited securities under BITO code.
- Suspension enacted under ASX Listing Rule 17.3.4.
- Suspension pending compliance with ASX Listing Rule 2.5.
- Applies only to BITO securities, not affecting other Biotron Limited securities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bioxyne Limited (BXN) ORDINARY FULLY PAID |
Consumer Staple |
$94 |
Application for quotation of securities - BXN
|
15 Dec 2025 9:13AM |
$0.039 |
$0.043 |
risen by
10.26%
|
|
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$692 |
Weekly Estimated NTA as at 12 December 2025
|
15 Dec 2025 9:13AM |
$3.140 |
$3.100 |
fallen by
1.27%
|
|
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$11,744 |
Update - Notification of buy-back - LNW
|
15 Dec 2025 9:12AM |
$151.410 |
$146.350 |
fallen by
3.34%
|
|
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$67 |
Monthly Funds Under Management - 30 November 2025
|
15 Dec 2025 9:12AM |
$0.660 |
$0.680 |
risen by
3.03%
|
|
PCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Pengana Capital Group Limited (ASX: PCG) reported funds under management (FUM) as of 30 November 2025 at $3,856.48 million.
- The FUM increased from $3,840.24 million at 31 October 2025.
- The announcement was approved by Paula Ferrao, Company Secretary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$35,254 |
2025 Annual Report and date of 2026 Annual General Meeting
|
15 Dec 2025 9:12AM |
$56.710 |
$57.150 |
risen by
0.78%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$315 |
Update - Notification of buy-back - AMH
|
15 Dec 2025 9:12AM |
$1.035 |
$0.995 |
fallen by
3.86%
|
|
| Kip McGrath Education Centres Limited (KME) ORDINARY FULLY PAID |
Consumer Discretionary |
$33 |
Update - Notification of buy-back - KME
|
15 Dec 2025 9:12AM |
$0.570 |
$0.580 |
risen by
1.75%
|
|
| Mt Malcolm Mines NL (M2M) ORDINARY FULLY PAID |
Materials |
$7 |
M2M Secures 500k TPA Processing Mill
|
15 Dec 2025 9:12AM |
$0.012 |
$0.014 |
risen by
16.67%
|
|
M2M - Price-sensitive ASX Announcement
Full Release
Key Points
- Mt Malcolm Mines NL (M2M) has secured a 500,000 tpa carbon-in-leach (CIL) gold processing plant.
- The plant components were acquired from Absolute West Pty Ltd for $550,000 plus GST.
- A deposit of $100,000 is payable on execution, with the balance in two instalments upon delivery.
- The acquisition includes major components like crushing, milling, power, pumps, coarse gold circuit, and elution extraction.
- This positions M2M as one of few juniors with such processing capabilities in a prolific gold region.
- The plant is relocation-ready and can be operational within 12–15 months after the final investment decision.
- The acquisition enables future self-processing and generates cash flow through toll-milling.
- M2M aims to become a self-sufficient gold producer in Leonora, where processing capacity is limited.
- Discussions are underway for a feasibility study on developing a fully functional processing facility.
- A detailed relocation, refurbishment, and commissioning plan will be announced in upcoming months.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$36 |
Update - Notification of buy-back - MEC
|
15 Dec 2025 9:11AM |
$1.165 |
$1.140 |
fallen by
2.15%
|
|
| Connexion Mobility Ltd (CXZ) ORDINARY FULLY PAID |
Information Technology |
$22 |
Update - Notification of buy-back - CXZ
|
15 Dec 2025 9:11AM |
$0.026 |
$0.027 |
risen by
3.85%
|
|
| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$27 |
Maiden Drilling Set to Commence at Los Lirios Project
|
15 Dec 2025 9:11AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drill program to commence in early January 2026.
- Fully funded program targeting high-grade antimony under historical workings.
- Phase 1 comprises 1,500-2,000 meters of diamond drilling.
- Aim to deliver maiden JORC resource by Q3 2026.
- Parallel advancement at Los Lirios and Tecomatlán Plant for production readiness.
- Part of a larger 2026 exploration campaign to unlock full scale potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$110 |
PTX secures EU Authorisation to commence PTX-100 Trial
|
15 Dec 2025 9:10AM |
$0.089 |
$0.105 |
risen by
17.98%
|
|
PTX - Price-sensitive ASX Announcement
Full Release
Key Points
- Prescient Therapeutics Limited secures EU authorisation to commence the PTX-100 trial.
- The trial targets patients with relapsed/refractory Cutaneous T-cell Lymphoma (CTCL) in Italy.
- PTX-100 is a first-in-class therapy targeting cancer growth pathways.
- The trial is advancing into Phase 2a with recruitment beginning in Europe.
- The European Clinical Trials Information System (CTIS) granted the authorisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$101 |
Update - Notification of buy-back - CAM
|
15 Dec 2025 9:10AM |
$0.690 |
$0.690 |
fallen by
0%
|
|
| Cynata Therapeutics Limited (CYP) ORDINARY FULLY PAID |
Health Care |
$69 |
Patient Enrolment Complete in Phase 2 aGvHD Clinical Trial
|
15 Dec 2025 9:09AM |
$0.265 |
$0.290 |
risen by
9.43%
|
|
CYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Patient enrolment completed for Phase 2 aGvHD clinical trial.
- 65 participants enrolled across the USA, Europe, and Australia.
- Participants received either steroids plus CYP-001 or steroids plus placebo.
- Primary evaluation period to conclude in March 2026, results expected by June 2026.
- CYP-001 is designed to improve response rates and survival in aGvHD.
- Phase 1 trial showed 87% overall response and no serious adverse events.
- CYP-001 has Orphan Drug Designation by the US FDA for aGvHD treatment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$11,744 |
LNW Form 3-Amendment (Fine Capital)
|
15 Dec 2025 9:09AM |
$151.410 |
$146.350 |
fallen by
3.34%
|
|
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$234 |
Trading Halt
|
15 Dec 2025 9:08AM |
$0.640 |
$0.620 |
fallen by
3.13%
|
|
IMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Intelligent Monitoring Group Limited.
- Pending announcement regarding proposed equity raising.
- Halt effective from 15 December 2025.
- Trading expected to resume on 17 December 2025 or upon announcement.
- No known reasons to deny the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nova Minerals Limited (NVA) ORDINARY FULLY PAID |
Materials |
$428 |
Suspension from Quotation
|
15 Dec 2025 9:08AM |
$1.030 |
$1.030 |
fallen by
0%
|
|
| Brazilian Rare Earths Limited (BRE) ORDINARY FULLY PAID |
Materials |
$559 |
Amargosa Bauxite Presentation
|
15 Dec 2025 9:08AM |
$4.000 |
$4.040 |
risen by
1%
|
|
| Meridian Energy Limited (MEZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$6,356 |
Financial assistance in connection with FY26 Equity Plan
|
15 Dec 2025 9:08AM |
$4.800 |
$4.860 |
risen by
1.25%
|
|